Effectiveness and safety evaluation of dementia medical care using online medical care

Phase 1

• Conditions: dementia

• Registration Number: JPRN-UMIN000040890
• Lead Sponsor: Keio University School of Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-06-25
• Study Completion: 2023-03-31
• Last Update Posted: 1 April 2024

Recruitment & Eligibility

• Status: Complete: follow-up continuing
• Sex: All
• Target Recruitment: 13

Inclusion Criteria

Not provided

Exclusion Criteria

Person with a history of substance use disorder other than smoking or being treated Person who has a history of epilepsy or is being treated Persons receiving antidepressants, antipsychotics, hypnotics including long-term sleeping pills Persons with a history of psychiatric/neurological disorders that affect cognitive function Persons with serious complications

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The main endpoints in this study are measured at the start of the study (0 weeks), 24 weeks, and 48 weeks by the three-time evaluation Zarit care burden scale.

Secondary Outcome Measures

Name	Time	Method
Cognitive function(MMSE), clinical dementia rating(CDR), questionnaire version Neuropsychiatric Inventory-Brief Questionnaire Form (NPI-Q), Geriatric depression scale 15 (GDS15) at the start of the study (0weeks), 24 weeks, 48weeks 3evaluations.